Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Key facts SKU: ALP-IGF Form: Lyophilised powder Presentation: Mass per vial as selected on the product page Appearance (typical): White to off-white lyophilised powder Intended laboratory context Controlled in-vitro models where IGF-axis biology is studied under institutional protocols Analytical characterisation and method development Non-clinical peptide handling and preparation workflows in laboratory settings Specifications Batch identity and purity parameters appear on the COA where stated for the lot supplied Handle as potent laboratory peptide per SDS Documentation scope may be limited to in-house or supplier release records for some lots (see notice in short description) Documentation and batch release COA and SDS are supplied with released lots within the scope described on this page
SURMOUNT-4 Investigators
Health Improvements Besides weight loss, bariatric surgery provides many health benefits
When MOAA Speaks, Congress Listens Learn more about MOAAs key advocacy issues, and contact your elected officials using our messaging platform.
What the Harvard Study Found about Pregnancy and GLP-1s Researchers analyzed 3,572 pregnancies involving women who were taking GLP-1 receptor agonists before conception
Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, et al
